Skip to main content
Caplight Logo









Merlin Biotech

Merlin Biotech

Private
Doylestown, PennsylvaniaHealthcare & Life Scienceshttps://www.merlinbiotech.com/

Last Round

Seed Round

Aug 11, 2026

Total Funding Raised

$1M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Merlin Biotech is a biotechnology company that develops novel mRNA-based therapeutics and vaccines for oncology, chronic hepatitis B, and Lyme disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

mRNA therapeuticslipid nanoparticleLNPcancer immunotherapymRNA vaccinedrug deliverybiotech R&Dprecision medicinesolid tumor therapyhepatitis B treatmentLyme disease vaccineIND-enabling studiesnext-gen vaccinesmRNA platformbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Merlin Biotech Comparables

Compare Merlin Biotech with similar companies based on industry and business-model similarity.

Merlin Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Strand Therapeutics
77%
RNAimmune
76%
Replicate Bioscience
76%

Merlin Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundAug 11, 2026
SeedFeb 11, 2025
SeedJan 25, 2024
DebtNov 2, 2023
DebtJan 5, 2023
Accelerator
Dec 1, 2022

Merlin Biotech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 11, 2026

    $50K raised in Seed Round.

  • Feb 11, 2025

    $100K raised from The Alliance for Health Equity.

Merlin Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Merlin Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Merlin Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersDoylestown, Pennsylvania
Year Founded2022
Last FundingAug 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?